NEW PRODUCTS
Medtronic Inc., Fridley, has finished randomizing Symplicity HTN-3, its U.S. clinical trial of the Symplicity renal denervation system for treatment-resistant hypertension.
DEBT AND EQUITIES
Wireless Ronin Technologies Inc., Minnetonka, has been notified by the Nasdaq Stock Market that trading in the company's securities will be suspended on May 31. The company had been previously notified that its shareholder equity falls under the minimum for the Nasdaq Capital Market. Wireless Ronin does not intend to appeal the delisting. The company's common stock will trade on the OTCQB, which is an electronic trading platform of the OTC Markets Group. The company's trading symbol will remain RNIN.
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More From Star Tribune
More From Business
Business
Ramstad: Gustavus president Bergman calls aid glitch a 'massive disruption'
While attention focused on Gaza protests, colleges don't know who will be enrolled this fall.
Business
Writing is hard work, with the goal of making it look easy
Author Paul Auster, who died April 30, had advice for other writers, including that every word counts and every comma is important.
Business
Business
Making a living as an artisan is hard but not impossible with financial planning
Becoming a furniture-maker or blacksmith can be a passion pursuit as well as a lucrative career if you keep money matters in mind.
Local
Minneapolis rideshare controversy shows growing power of progressive Democrats
Gov. Walz's administration signals it is not comfortable with a compromise bill as Uber and Lyft threaten to leave.
